Recent studies revealed that in addition to sequence variants, CEBPA promoter methylation also results in silencing of the gene; thus, epigenetic control of expression of genes crucial for hematopoiesis may also contribute to the pathogenesis of AML or MDS [4,5]. The gene discussed is CEBPA; the disease is myelodysplastic syndrome.